Kathy Yi - Net Worth and Insider Trading
Kathy Yi Net Worth
The estimated net worth of Kathy Yi is at least $69,010 dollars as of 2024-11-13. Kathy Yi is the EVP & CFO of Sangamo Therapeutics Inc and owns about 25,512 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $69,010. Details can be seen in Kathy Yi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kathy Yi has not made any transactions after 2019-05-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kathy Yi
Kathy Yi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kathy Yi owns 3 companies in total, including Sangamo Therapeutics Inc (SGMO) , Theseus Pharmaceuticals Inc (THRX) , and Cerevel Therapeutics Holdings Inc (CERE) .
Click here to see the complete history of Kathy Yi’s form 4 insider trades.
Insider Ownership Summary of Kathy Yi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2019-05-15 | Senior VP & CFO |
| THRX | Theseus Pharmaceuticals Inc | 2021-10-06 | director |
| CERE | Cerevel Therapeutics Holdings Inc | 2020-10-27 | Chief Financial Officer |
Kathy Yi Latest Holdings Summary
Kathy Yi currently owns a total of 1 stock. Kathy Yi owns 25,512 shares of Sangamo Therapeutics Inc (SGMO) as of May 15, 2019, with a value of $69,010.
Latest Holdings of Kathy Yi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2019-05-15 | 25,512 | 2.71 | 69,010 |
Holding Weightings of Kathy Yi
Kathy Yi Form 4 Trading Tracker
According to the SEC Form 4 filings, Kathy Yi has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 5,000 shares on May 15, 2019, which brought Kathy Yi around $50,000.
Insider Trading History of Kathy Yi
- 1
Kathy Yi Trading Performance
Kathy Yi Ownership Network
Ownership Network List of Kathy Yi
Ownership Network Relation of Kathy Yi
Kathy Yi Owned Company Details
What does Sangamo Therapeutics Inc do?
Who are the key executives at Sangamo Therapeutics Inc?
Kathy Yi is the Senior VP & CFO of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .
Sangamo Therapeutics Inc (SGMO) Insider Trades Summary
Over the past 18 months, Kathy Yi made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.
Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sangamo Therapeutics Inc Insider Transactions
Kathy Yi Mailing Address
Above is the net worth, insider trading, and ownership report for Kathy Yi. You might contact Kathy Yi via mailing address: 501 Canal Blvd., Point Richmond Tech Center, Richmond Ca 94804.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
